FORA Capital’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,457
| Closed | -$235K | – | 654 |
|
|
2025
Q1 | $235K | Buy |
+9,457
| New | +$235K | 0.02% | 429 |
|
|
2024
Q4 | – | Sell |
-28,614
| Closed | -$431K | – | 542 |
|
|
2024
Q3 | $431K | Buy |
+28,614
| New | +$431K | 0.05% | 313 |
|
|
2022
Q2 | – | Sell |
-8,131
| Closed | -$615K | – | 627 |
|
|
2022
Q1 | $615K | Buy |
+8,131
| New | +$615K | 0.11% | 249 |
|
|
2021
Q1 | – | Sell |
-287
| Closed | -$17K | – | 1016 |
|
|
2020
Q4 | $17K | Sell |
287
-137
| -32% | -$8.12K | ﹤0.01% | 884 |
|
|
2020
Q3 | $25K | Sell |
424
-12,229
| -97% | -$721K | 0.02% | 552 |
|
|
2020
Q2 | $664K | Buy |
12,653
+11,132
| +732% | +$584K | 0.23% | 120 |
|
|
2020
Q1 | $51K | Sell |
1,521
-4,662
| -75% | -$156K | 0.01% | 769 |
|
|
2019
Q4 | $280K | Buy |
+6,183
| New | +$280K | 0.03% | 537 |
|